Avricore Health Inc V.AVCR

Alternate Symbol(s): AVCRF

Healthcare Diagnostics & Research

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.

TSXV:AVCR - Post by User

Avricore Health Inc

Bullboard Posts

Comment by StockDoc60on Sep 30, 2020 4:31pm

206 Views

Post# 31643704

RE:RE:AVCR-TSXV HEALTH CDA APPROVES RAPID TEST

Forgot to add in my previous post :

There was no indication that the letter of intent,AVCR mentioned was with Abbott Laboratories .

Also, a LOI is not a contract so revenue will not be generated anytime soon unless there is a formal contract .

Based on my research into the HealthTab in 2019, It was practically unknown in 90% of the pharmacies I contacted in GTA

Covid testing will need to be widespread and efficient .In my opinion ,this company is probably not ready for such volume at this time and will not capitalize on this for some time .

As a long time time investor who has been badly burned by this stock I raised these flags of caution !!